Match Document Document Title
7615368 Microarrays of polypeptides  
Microarrays of polypeptides on a solid support are provided. The microarray compositions find use in the multiplexed detection and quantitation of ligands, e.g. antigens or antibodies, in a...
7598343 Pharmaceutical formulations of bivalirudin and processes of making the same  
Pharmaceutical batch(es) or pharmaceutical formulation(s) comprising bivalirudin as the active ingredient, and a method of preparing the pharmaceutical batch(es) or pharmaceutical formulation(s)....
7582728 Microwave-assisted peptide synthesis  
An instrument and method for accelerating the solid phase synthesis of peptides is disclosed. The method includes the steps of deprotecting a protected first amino acid linked to a solid phase...
7582727 Pharmaceutical formulations of bivalirudin and processes of making the same  
Pharmaceutical batch(es) or pharmaceutical formulation(s) comprising bivalirudin as the active ingredient, and a method of preparing the pharmaceutical batch(es) or pharmaceutical formulation(s)....
7566697 Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides  
The present invention provides methods of assembling oligopeptides or polypeptides in a native chemical ligation reaction that eliminates the formation of unwanted side products resulting from the...
7507791 Solid phase peptide synthesis of tri-peptide derivatives  
The present invention relates to a process for the preparation of a peptide derivative, and more preferably tri-peptide derivatives, of the formula wherein Tos has the meaning of...
7473679 Treatments employing neuronal exocytosis-inhibiting peptides  
The peptide has a sequence of 3 to 30 adjacent amino acids from the amino end of protein SNAP-25 and is useful as neuronal exocytosis inhibitor. The cosmetic and pharmaceutical compositions contain...
7459522 Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use  
Novel peptide dimers are provided that bind and activate the erythropoietin receptor (EPO-R) or otherwise act as an EPO agonist. The novel compounds have a first peptide chain R 1 and a second...
7452856 Antibacterial peptide  
The present invention provides a novel peptide based on CAP11 as well as provides an antibacterial agent, an LPS-cell-binding inhibitor, and a drug such as a bacterial-infection-treating agent or...
7425608 Method of making metallopeptides  
Method of making metallopeptides is provided, for use in biological, pharmaceutical and related applications. The metallopeptides are made of peptides, peptidomimetics and peptide-like constructs,...
7423117 Surface-functionalized carrier material and solid phase synthesis method  
The invention concerns a novel surface-functionalized carrier material with a polymeric surface and at least one linker compound according to the general formula (I), which is covalently bound to...
7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis  
The invention is directed to a pharmacologically active peptide conjugate having a reduced tendency towards enzymatic cleavage comprising a pharmacologically active peptide sequence (X) and a...
7414106 Synthesis of peptide α-thioesters  
Disclosed herein is a new method for the solid phase peptide synthesis (SPPS) of C-terminal peptide α thioesters using Fmoc/t-Bu chemistry. This method is based on the use of an aryl hydrazine...
7393920 Microwave-assisted peptide synthesis  
An instrument and process for accelerating the solid phase synthesis of peptides is disclosed. The method includes the steps of deprotecting a protected first amino acid linked to a solid phase...
7388089 Anti-arthropod vector vaccines method of selecting and uses thereof  
The present invention provides methods of selecting and uses of anti-arthropod vector vaccines to prevent Leishmaniasis. The present invention also provides compositions for vaccines to prevent...
7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins  
The invention provides methods of chemically synthesizing chimeric proteins comprising at least a portion of an immunoglobulin constant region and a biologically active molecule.
7375085 Melanocyte-stimulating hormone inhibitors  
In the present specification is disclosed a melanocyte-stimulating hormone inhibitory composition which comprises, as the active ingredient, a di- or tripeptide derivative having a certain naphthyl...
7314708 Method and apparatus for electronic synthesis of molecular structures  
A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic...
7312195 Cyclised conotoxin peptides  
This invention relates to cyclised conotoxin peptides, processes for their preparation and their pharmaceutical use.
7273846 Selective melanin-concentrating hormone type-1 receptor agonists  
The present invention features truncated hMCH analogs selectively active at MCH-1R over MCH-2R. Using amino acid numbering provided in hMCH, the featured analogs contain an X 6 which is either a...
7268210 PEG-LHRH analog conjugates  
PEG-LHRH analog conjugates, where a PEG moiety is covalently bound to a serine residue of a LHRH analog, and methods for producing these conjugates are provided in the present invention. Also...
7259142 Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use  
A compound of formula: in which (i) aa 1 is Adi and aa 4 is Glu or (ii) each of aa 1 and aa 4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compound (and its conjugates)...
7247701 Amino amides, peptides and peptidomimetics  
Synthetic methods and compounds involving amino amides, peptides and peptidomimetics. Amino amide derivatives are prepared via the one-step three-component reaction of a glyoxamide, an amine, and...
7244815 Attachment and elaboration strategies for inverse peptide synthesis  
The present invention provides a process for preparing a peptide of formula I): Sub-[L]-[N(R 1 )-A-C(O)] p —[NH-A-C(O)] n+m —OH ...
7214769 Method for inverse solid phase synthesis of peptides  
The present invention provides a process for preparing a peptide of formula (I): Sub-[L]-[NH-A-C(O)] n+m —OH (I)
RE39606 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries  
The present invention provides labeled synthetic libraries of random oligomers and methods and apparatus for generating labeled synthetic oligomer libraries. Each member of such a library is...
7192713 Stabilized compounds having secondary structure motifs  
The present invention provides novel stabilized crosslinked compounds having secondary structure motifs, libraries of these novel compounds, and methods for the synthesis of these compounds...
7176282 Solid-phase peptide synthesis and agent for use in such synthesis  
The present invention relates to an improved process for the production of peptides by solid-phase synthesis. The invention also relates to agents, which are useful in solid-phase peptide synthesis.
7166696 Solid phase synthesis supports and methods  
Functionalized supports and methods for solid phase synthesis. Preferably, the functionalized support is azlactone-functionalized.
7160862 Integrin binding motif containing peptides and methods of treating skeletal diseases  
Peptide sequences comprising 10 to 50 amino acids are disclosed. The sequences are characterized by containing at least one of an integrin binding motif such as an RGD sequence, a glycosaminoglycan...
7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same  
A solid phase synthesis method for preparing peptide-spacer-lipid conjugates, the peptide-spacer-lipid conjugates synthesized by the method, and liposomes containing the peptide-spacer-lipid...
7138489 Method for producing a modified peptide  
The present invention is a method for producing a peptide or a protein in which a side chain contains a modified amino acid residue, which comprises chemically producing a peptide fragment...
7122628 Process for the synthesis of a peptide having a Trp residue  
A process for the solid phase synthesis of a peptide having at least one thyptophan residue, wherein said method comprises temporarily protecting the indole ring of said tryptophan residue with a...
7119064 Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules  
The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as modulators of...
7109162 Plant derived antioxidants  
The present invention relates to a purified antioxidant polypeptide, a method of isolating and purifying said polypeptide, and method of enhancing antioxidant properties of a composition comprising...
7094871 Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution  
The present invention provides methods, apparatus and kits for synthesizing assembled peptides and proteins on a solid phase with sequential ligation of three or more unprotected peptide segments...
7094609 Spatially addressable combinatorial chemical arrays in encoded optical disk format  
A method for preparing very large spatially-addressable arrays of chemical compounds by light-directed synthesis is provided, wherein the light is provided by a laser and the compounds are arrayed...
7091314 Intermediates and methods for making heptapeptide oxytocin analogues  
More efficient and/or economical methods for synthesizing heptapeptide alcohol analogs of oxytocin are provided along with novel intermediates which are useful in synthesizing such oxytocin...
7083914 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds  
A method and apparatus for the physico-chemical encoding of a collection of beaded resin (“beads”) to determine the chemical identity of bead-anchored compounds by in-situ interrogation of...
7070936 Method for designing protein kinase inhibitors  
The present invention provides a method for identifying inhibitors of protein kinases. Methods are also provided for inhibiting protein kinase activity. Specific non-peptide protein tyrosine kinase...
7067326 Synthetic receptors, libraries and uses thereof  
Libraries of synthetic receptors are disclosed. The receptors include a polyfunctional organic template which is covalently linked to two or more oligomers. The oligomers may be the same or...
7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same  
The present invention relates to a fusion peptide wherein a self cell-penetrating Tat peptide having a self penetrating signal is bound to a human parathyroid hormone-derived peptide, a preparation...
7049293 Peptide and osteogenetic accelerator  
A peptide has any one of the sequences SEQ ID NO.1 to SEQ ID NO.8, or has a sequence derived from any one of the sequences SEQ ID NO.1 to SEQ ID NO.8 by substitution, deletion or addition of one or...
7045503 Radiometal-binding peptide analogues  
Novel metal binding ligands are disclosed that may be coupled to peptides for use in methods of diagnosis and therapy. Peptides containing the ligands are produced using a method wherein ligand...
7030217 Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution  
The present invention provides methods, apparatus and kits for synthesizing assembled peptides and proteins on a solid phase with sequential ligation of three or more unprotected peptide segments...
7030216 Peptoids incorporating chemoselective functionalities  
Molecules having potential biological activity, particularly peptoids, that are conjugated to solid phase supports, spacer groups, and/or ligation moieties, and methods of their preparation, are...
7026114 Methods and compositions for monitoring polymer array synthesis  
VLSIPS™ manufacturing processes are of increasing commercial importance. The present invention provides methods and compositions for monitoring the efficiency and quality of polymer synthesis in...
7015192 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides  
The peptide has a sequence of 3 to 30 adjacent amino acids from the amino end of protein SNAP-25 and is useful as neuronal exocytosis inhibitor. The cosmetic and pharmaceutical compositions contain...
7001883 Cyclized conotoxin peptides  
This invention relates to cyclized conotoxin peptides, processes for their preparation and their pharmaceutical use.
6995136 Peptide fragments of murine epidermal growth factor as laminin receptor targets  
A peptide factor, its analogs and methods of using such peptide factor derived from murine epidermal growth factor peptide is disclosed wherein the peptide factor is modified to protect it from...